← Eichor
Condition: Cardiomyopathy Hypertrophic Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cardiomyopathy Hypertrophic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Application of T1 Mapping in Real-World
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07354646Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
Phase 4 · 4 location(s) · Morten Steen Kvistholm Jensen · NCT05569382Molecular and Imaging Studies of Cardiovascular Health and Disease
Phase N/A · 1 location(s) · National Heart Centre Singapore · NCT02804269Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial
NA · 1 location(s) · University of Manchester · NCT07120776Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585Large Language Models To Improve the Quality of Care of Cardiology Patients
NA · 1 location(s) · Stanford University · NCT06935253Evaluation of HEArt invoLvement in Patients With FABRY Disease
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT03362164Austrian Hypertrophic Cardiomyopathy Registry
Phase N/A · 15 location(s) · Medical University of Graz · NCT06368518AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · 8 location(s) · Peerbridge Health, Inc · NCT06699056A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06146660Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Phase N/A · 1 location(s) · Fatebenefratelli Hospital · NCT05081115Multicentre Hypertrophic Cardiomyopathy Registry
Phase N/A · 1 location(s) · University of Manchester · NCT07381894LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atri
Phase 3 · 17 location(s) · Rennes University Hospital · NCT07202897Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07382128Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Phase N/A · 1 location(s) · Michael Ayers · NCT06023186Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy
NA · 1 location(s) · Meshalkin Research Institute of Pathology of Circulation · NCT07372196Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
NA · 1 location(s) · Technical University of Munich · NCT07077005A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT06816251Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07383025Study of the Progression of Chronic Cardiovascular Conditions
Phase N/A · 1 location(s) · Prolaio · NCT07420907Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients
NA · 1 location(s) · Istanbul University - Cerrahpasa · NCT06490250A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · 15 location(s) · Bristol-Myers Squibb · NCT07361289the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease
Phase N/A · 1 location(s) · Caroline Michaela Kistorp · NCT06776419Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443French Hypertrophic Cardiomyopathy Observatory
Phase N/A · 1 location(s) · French Cardiology Society · NCT01091480Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
NA · 1 location(s) · University of California, San Francisco · NCT05818605REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
NA · 2 location(s) · SuZhou Sinus Medical Technologies Co.,Ltd · NCT07006493Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT03479580Valsalva SBP Drop and LVOT Obstruction
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT07483125
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.